Baxter International Inc.
https://www.baxter.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Baxter International Inc.
EU Moment Of Truth For Lecanemab & 14 Other Drugs
Eisai/Biogen could this week learn whether the European Medicines Agency will give the thumbs up to market lecanemab across the EU for early Alzheimer’s disease.
Japan Phase III Wins, Asian Alliances Buoy Kissei's Linzagolix
While its European licensee is preparing for an imminent launch, Kissei has also been expanding its partnerships in Asia for female health product linzagolix. A new alliance is also being sought in the US to assist with a new trial and NDA refiling there.
Almirall Pleased With Promising Start For Ebglyss
The Barcelona-headquartered group’s Lilly-partnered atopic dermatitis drug is enjoying a decent launch in Germany and reimbursement has just been secured in the UK.
Lucky No. 13? Artiva Goes Public, Rises In First Day Of Trading
Artiva grossed $167m by selling more shares than previously planned, but at a significantly lower price per share than it proposed earlier in the week, to fund its NK cell therapy programs.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Medical Devices
- Pharmaceuticals
- Services
-
Pharmaceuticals
- Drug Delivery
- Nutraceuticals
-
Medical Devices
- Infusion Therapy Equipment and Supplies
-
Surgical Equipment & Devices
- Surgical Sealants
- Other Names / Subsidiaries
-
- AesRX LLC
- Althin Medical A.B.
- Chatham Therapeutics
- Cheetah Medical
- Claris Injectables Limited
- Fusion Medical Technologies, Inc.
- Gambro AB
- Immuno-US
- Prism Pharmaceuticals, Inc.
- Renal Therapy Services
- SIGMA International Geneeral Medical Apparatus
- SuppreMol GmbH
- Synovis Life Technologies, Inc.
- Wound Care Technologies, Inc.
- Baxter Healthcare Corporation
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice